FI861704A - Tricykliska oxindol-antiinflammatoriska aemnen. - Google Patents

Tricykliska oxindol-antiinflammatoriska aemnen. Download PDF

Info

Publication number
FI861704A
FI861704A FI861704A FI861704A FI861704A FI 861704 A FI861704 A FI 861704A FI 861704 A FI861704 A FI 861704A FI 861704 A FI861704 A FI 861704A FI 861704 A FI861704 A FI 861704A
Authority
FI
Finland
Prior art keywords
sub
tricyclic
antiinflammatory
aemnen
oxindol
Prior art date
Application number
FI861704A
Other languages
English (en)
Other versions
FI79319C (fi
FI79319B (fi
FI861704A0 (fi
Inventor
Jr Lawrence Sherman Melvin
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of FI861704A publication Critical patent/FI861704A/fi
Publication of FI861704A0 publication Critical patent/FI861704A0/fi
Application granted granted Critical
Publication of FI79319B publication Critical patent/FI79319B/fi
Publication of FI79319C publication Critical patent/FI79319C/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56Ring systems containing three or more rings
    • C07D209/58[b]- or [c]-condensed
    • C07D209/70[b]- or [c]-condensed containing carbocyclic rings other than six-membered
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Rheumatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pain & Pain Management (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Polymers With Sulfur, Phosphorus Or Metals In The Main Chain (AREA)
  • Medicinal Preparation (AREA)
  • Photoreceptors In Electrophotography (AREA)
  • Filling Or Discharging Of Gas Storage Vessels (AREA)
  • Optical Fibers, Optical Fiber Cores, And Optical Fiber Bundles (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
FI861704A 1984-08-24 1986-04-23 Foerfarande foer framstaellning av nya terapeutiskt anvaendbara tricykliska oxindolkarboxamidderivat. FI79319C (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US8401371 1984-08-24
PCT/US1984/001371 WO1986001510A1 (en) 1984-08-24 1984-08-24 Tricyclic oxindole antiinflammatory agents

Publications (4)

Publication Number Publication Date
FI861704A true FI861704A (fi) 1986-04-23
FI861704A0 FI861704A0 (fi) 1986-04-23
FI79319B FI79319B (fi) 1989-08-31
FI79319C FI79319C (fi) 1989-12-11

Family

ID=22182243

Family Applications (1)

Application Number Title Priority Date Filing Date
FI861704A FI79319C (fi) 1984-08-24 1986-04-23 Foerfarande foer framstaellning av nya terapeutiskt anvaendbara tricykliska oxindolkarboxamidderivat.

Country Status (21)

Country Link
US (1) US4695571A (fi)
EP (1) EP0173520B1 (fi)
JP (1) JPS6157554A (fi)
KR (1) KR870001144B1 (fi)
AT (1) ATE49211T1 (fi)
AU (1) AU553859B2 (fi)
CA (1) CA1244427A (fi)
DE (1) DE3575140D1 (fi)
DK (1) DK160098C (fi)
EG (1) EG17287A (fi)
ES (2) ES8704497A1 (fi)
FI (1) FI79319C (fi)
GR (1) GR852026B (fi)
HU (2) HU203350B (fi)
IE (1) IE58739B1 (fi)
IL (1) IL76175A (fi)
PH (1) PH23065A (fi)
PL (2) PL147393B1 (fi)
PT (1) PT81004B (fi)
WO (1) WO1986001510A1 (fi)
ZA (1) ZA856403B (fi)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3531678A1 (de) * 1985-09-05 1987-03-12 Boehringer Mannheim Gmbh Neue pyrrolo-benzimidazole, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
JPS63223492A (ja) * 1987-03-11 1988-09-16 Okawara Mfg Co Ltd 熱交換器
HU215112B (hu) * 1989-01-10 1998-12-28 Pfizer Inc. Eljárás gyulladáscsökkentő 1-heteroaril-3-acil-2-oxindol-származékok előállítására
HU217072B (hu) * 1989-01-10 1999-11-29 Pfizer Inc. 1-Heteroaril-oxindol-3-karboxamid-származékok, azok előállítása, és az azokat tartalmazó gyógyszerkészítmények
US5300655A (en) * 1989-04-18 1994-04-05 Pfizer Inc. 2-carboxy-thiophene derivatives
US5047554A (en) 1989-04-18 1991-09-10 Pfizer Inc. 3-substituted-2-oxindole derivatives
JPH04217684A (ja) * 1990-05-30 1992-08-07 Shionogi & Co Ltd アルド−ス還元酵素阻害物質
DE4027592A1 (de) * 1990-08-31 1992-03-05 Beiersdorf Ag Neue pyrrolobenzimidazole, imidazobenzoxazinone und imidazochinolone, verfahren zu ihrer herstellung und ihre verwendung sowie die verbindungen enthaltende zubereitungen
DE60234057D1 (de) 2001-07-25 2009-11-26 Raptor Pharmaceutical Inc Zusammensetzungen und verfahren zur modulation des transports durch die blut-hirn-schranke
WO2005041957A1 (en) * 2003-10-29 2005-05-12 Pfizer Products Inc. Oxindole derivatives and their use as phosphodiesterase type 2 inhibitors
EP1889198B1 (en) 2005-04-28 2014-11-26 Proteus Digital Health, Inc. Pharma-informatics system
WO2008036682A2 (en) 2006-09-18 2008-03-27 Raptor Pharmaceutical Inc. Treatment of liver disorders by administration of receptor-associated protein (rap)-conjugates
DK3395372T3 (da) 2009-02-20 2022-04-19 Enhanx Biopharm Inc System til afgivelse af glutathion-baseret medikament
EP2427178B1 (en) 2009-05-06 2023-01-04 Laboratory Skin Care, Inc. Dermal delivery compositions comprising active agent-calcium phosphate particle complexes and methods of using the same
US20120077778A1 (en) 2010-09-29 2012-03-29 Andrea Bourdelais Ladder-Frame Polyether Conjugates

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE756447A (fr) * 1969-10-15 1971-03-22 Pfizer Oxindolecarboxamides
US3749731A (en) * 1971-07-08 1973-07-31 Warner Lambert Co 2-oxo-n-(2-thiazolyl)-3-indoline-carboxamide
US4644005A (en) * 1984-10-31 1987-02-17 Pfizer Inc. Oxindole antiinflammatory agents

Also Published As

Publication number Publication date
PL147393B1 (en) 1989-05-31
IL76175A0 (en) 1985-12-31
IE852081L (en) 1986-02-24
FI79319C (fi) 1989-12-11
AU4663785A (en) 1986-02-27
ATE49211T1 (de) 1990-01-15
PT81004B (pt) 1987-12-30
DK160098C (da) 1991-06-24
KR870001144B1 (ko) 1987-06-11
HUT47580A (en) 1989-03-28
EP0173520A2 (en) 1986-03-05
FI79319B (fi) 1989-08-31
EG17287A (en) 1993-02-28
IE58739B1 (en) 1993-11-03
CA1244427A (en) 1988-11-08
EP0173520A3 (en) 1986-05-14
ES546377A0 (es) 1987-04-01
DE3575140D1 (de) 1990-02-08
PH23065A (en) 1989-03-27
US4695571A (en) 1987-09-22
ZA856403B (en) 1987-04-29
GR852026B (fi) 1985-12-19
PL147395B1 (en) 1989-05-31
HU902020D0 (en) 1990-07-28
DK382685A (da) 1986-02-25
KR870002143A (ko) 1987-03-30
EP0173520B1 (en) 1990-01-03
JPS6157554A (ja) 1986-03-24
ES8706116A1 (es) 1987-06-01
ES8704497A1 (es) 1987-04-01
WO1986001510A1 (en) 1986-03-13
DK160098B (da) 1991-01-28
FI861704A0 (fi) 1986-04-23
HU203238B (en) 1991-06-28
DK382685D0 (da) 1985-08-23
AU553859B2 (en) 1986-07-31
PL255089A1 (en) 1986-12-30
IL76175A (en) 1989-08-15
JPH0450316B2 (fi) 1992-08-13
PT81004A (en) 1985-09-01
ES552044A0 (es) 1987-06-01
HU203350B (en) 1991-07-29

Similar Documents

Publication Publication Date Title
FI861704A0 (fi) Tricykliska oxindol-antiinflammatoriska aemnen.
FI833047A (fi) Mellanprodukter foer framstaellning av omeprazol
MX154758A (es) Procedimiento para preparacion de derivados de succinimida
FI862757A0 (fi) Pyridonkarbonsyraderivat och foerfarande foer framstaellning av dessa.
MY129935A (en) Dihydropyridine derivatives useful in antitumor therapy
NO164351C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 5-alkyl-l-fenyl-2-piperazinoalkylpyrazolin-3-on-forbindelser.
MX170732B (es) Composicion de derivados de succinimida y su uso
ATE31295T1 (de) Benzoylharnstoffderivate.
ES457805A1 (es) Un procedimiento para la preparacion de derivados de tiou- rea.
ATE49410T1 (de) 1-aryl-5-alkoximinoalkylamino-pyrazole.
GR1000887B (el) Νεα παραγωγα σπιροφουρανης.
FI834410A0 (fi) Foerfarande foer framstaellning av pyrimidinonderivat
FI890187A0 (fi) Foerfarande foer framstaellning av hydroxialkylerande foereningar, saolunda erhaollna nya foereningar och deras anvaendning.
ES471207A1 (es) Metodo para la preparacion de nuevos derivados condensados de pirimidina
ATE65986T1 (de) Propanolabkoemmlinge.
ATE119883T1 (de) Thioformamidderivate.
ITMI931728A1 (it) Composti eterociclici ad attivita' cardiovascolare
ES474282A1 (es) Un procedimiento para producir un compuesto de piridazinoma.

Legal Events

Date Code Title Description
MM Patent lapsed

Owner name: PFIZER INC.